UBS Group AG Lowers Position in SunOpta, Inc. (STKL)

UBS Group AG reduced its stake in SunOpta, Inc. (NASDAQ:STKL) (TSE:SOY) by 2.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,594,268 shares of the company’s stock after selling 114,700 shares during the period. UBS Group AG owned approximately 6.51% of SunOpta worth $38,880,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the company. Hollencrest Securities LLC boosted its stake in shares of SunOpta by 40.0% in the first quarter. Hollencrest Securities LLC now owns 21,000 shares of the company’s stock valued at $146,000 after buying an additional 6,000 shares in the last quarter. Trexquant Investment LP bought a new stake in shares of SunOpta during the first quarter worth $181,000. Gamco Investors INC. ET AL boosted its stake in shares of SunOpta by 13.0% in the first quarter. Gamco Investors INC. ET AL now owns 27,000 shares of the company’s stock worth $188,000 after buying an additional 3,100 shares during the period. A.R.T. Advisors LLC bought a new stake in shares of SunOpta during the fourth quarter worth $207,000. Finally, Ellington Management Group LLC bought a new stake in shares of SunOpta during the fourth quarter worth $213,000. Institutional investors and hedge funds own 87.14% of the company’s stock.

Institutional Ownership by Quarter for SunOpta (NASDAQ:STKL)

SunOpta, Inc. (STKL) remained flat at $9.30 during midday trading on Monday. 408,647 shares of the stock were exchanged. The stock has a 50-day moving average price of $8.80 and a 200-day moving average price of $7.54. The firm’s market cap is $799.90 million. SunOpta, Inc. has a 12-month low of $3.87 and a 12-month high of $9.95.

SunOpta (NASDAQ:STKL) (TSE:SOY) last announced its quarterly earnings results on Wednesday, May 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.01. The company had revenue of $330 million during the quarter, compared to the consensus estimate of $344.20 million. SunOpta had a positive return on equity of 0.58% and a negative net margin of 3.95%. SunOpta’s revenue for the quarter was down 6.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.03 EPS. On average, analysts predict that SunOpta, Inc. will post $0.08 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by BBNS and is owned by of BBNS. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://baseballnewssource.com/markets/sunopta-inc-stkl-shares-sold-by-ubs-group-ag-updated/985187.html.

STKL has been the subject of a number of analyst reports. Wunderlich cut SunOpta from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $10.00 to $8.00 in a research note on Thursday, March 2nd. DA Davidson cut SunOpta from a “buy” rating to a “neutral” rating in a research note on Monday, March 6th. William Blair upgraded SunOpta from a “market perform” rating to an “outperform” rating in a research note on Tuesday, March 7th. Zacks Investment Research cut SunOpta from a “hold” rating to a “strong sell” rating in a research note on Thursday, March 9th. Finally, BMO Capital Markets restated a “buy” rating and set a $8.50 price objective on shares of SunOpta in a research note on Wednesday, April 26th. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. SunOpta has an average rating of “Buy” and a consensus price target of $9.10.

In other news, insider Robert Duchscher bought 5,800 shares of SunOpta stock in a transaction dated Friday, May 19th. The stock was acquired at an average cost of $8.94 per share, with a total value of $51,852.00. Following the acquisition, the insider now owns 5,800 shares of the company’s stock, valued at $51,852. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Jeffrey Gough bought 15,000 shares of SunOpta stock in a transaction dated Tuesday, May 16th. The stock was purchased at an average cost of $8.49 per share, with a total value of $127,350.00. Following the completion of the acquisition, the insider now directly owns 6,600 shares in the company, valued at approximately $56,034. The disclosure for this purchase can be found here. Insiders have acquired a total of 257,246 shares of company stock valued at $2,071,020 over the last ninety days. 1.88% of the stock is owned by company insiders.

SunOpta Company Profile

SunOpta Inc operates businesses focused on a healthy products portfolio. The Company operates through two segments: Global Ingredients and Consumer Products. The Global Ingredients segment aggregates its North American and international raw material sourcing and supply operating segments focused on the procurement, processing and sale of specialty and organic grains, seeds, fruits, grain- and cocoa-based ingredients, and other commodities, which are used in applications serving the natural and organic food industry.

Receive News & Ratings for SunOpta Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SunOpta Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.